Low eosinophil count predicts in-hospital mortality in cirrhosis with systemic inflammatory response syndrome

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 6, 2013, Pages 676-682

  Kotecha, Hardik L ^a   Arora, Anil ^a   Chawlani, Romesh ^a   Toshniwal, Jay ^a   Bansal, Naresh ^a   Tyagi, Pankaj ^a   Sharma, Praveen ^a   Kumar, Mandhir ^a   Kumar, Ashish ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

cirrhosis; eosinopenia; eosinophil count; mortality; procalcitonin; sepsis; systemic inflammatory response syndrome

Indexed keywords

ALCOHOL; PROCALCITONIN;

ABSOLUTE EOSINOPHIL COUNT; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD TURCOTTE PUGH SCORE; EOSINOPHIL COUNT; FEMALE; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SODIUM BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUDEN INDEX;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN; EOSINOPHILS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 84877031338     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835eb8f7     Document Type: Article

References (26)

1. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4:430-435.
2. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo end-stage liver disease. Hepatology 2001; 33:473-475.
3. Kumar A, Roberts D,Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
4. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155.
5. Li CH, Yang RB, Pang JH, Chang SS, Lin CC, Chen CH, et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med 2011; 18:121-126.
6. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. Diagn Microbiol Infect Dis 2012; 73:221-227.
7. Moretti D, Ramirez MM, Settecase CJ, Bagilet DH, Quaglino MB. Usefulness of procalcitonin upon admission to intensive care in the diagnosis and prognosis of sepsis. Med Intensiva 2012 [Epub ahead of print].
8. Povoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002; 28:235-243.
9. Shaaban H, Daniel S, Sison R, Slim J, Perez G. Eosinopenia: is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? J Crit Care 2010; 25:570-575.
10. Wibrow BA, Ho KM, Flexman JP, Keil AD, Kohrs DL. Eosinopenia as a diagnostic marker of bloodstream infection in hospitalized paediatric and adult patients: a case-control study. Anaesth Intensive Care 2011; 39:224-230.
11. Abidi K, Belayachi J, Derras Y, Khayari ME, Dendane T, Madani N, et al. Eosinopenia, an early marker of increased mortality in critically ill medical patients. Intensive Care Med 2011; 37:1136-1142.
12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
13. Bass DA. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 1975; 56:870-879.
14. Bass DA. Reproduction of the eosinopenia of acute infection by passive transfer of a material obtained from inflammatory exudate. Infect Immun 1977; 15:410-416.
15. Holland M, Alkhalil M, Chandromouli S, Janjua A, Babores M. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology 2010; 15:165-167.
16. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011; 9:107.
17. Elefsiniotis IS, Skounakis M,Vezali E, Pantazis KD, Petrocheilou A, Pirounaki M, et al. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol 2006; 18:525-530.
18. Bota DP, Van Nuffelen M, Zakariah AN, Vincent JL. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005; 146:347-351.
19. Connert S, Stremmel W, Elsing C. Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol 2003; 41:165-170.
20. Bass DA, Gonwa TA, Szejda P, Cousart MS, DeChatelet LR, McCall CE. Eosinopenia of acute infection: production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest 1980; 65:1265-1271.
21. Morgan JE, Beeson PB. Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol 1971; 52:214-220.
22. Gil H, Magy N, Mauny F, Dupond JL. Value of eosinopenia in inflammatory disorders: an 'old' marker revisited. Rev Med Interne 2003; 24:431-435.
23. Abidi K, Khoudri I, Belayachi J, Madani N, Zekraoui A, Zeggwagh AA, et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008; 12:R59.
24. Smithson A, Perello R, Nicolas JM. Is eosinopenia a reliable marker of sepsis? Crit Care 2009; 13:409.
25. Setterberg MJ, Newman W, Potti A, Smego RA Jr. Utility of eosinophil count as predictor of bacteremia. Clin Infect Dis 2004; 38:460-461.
26. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338:1592-1600.